HEAL4WARD

Doctoral Network for Wound Infection Advanced Care and Rapid Diagnosis

About the project

HEAL4WARD is a Marie Skłodowska-Curie Doctoral Network training 11 Doctoral Candidates (DCs) to develop next-generation solutions for the diagnosis and treatment of wound infections.

The project combines advanced nanomaterials, antimicrobial peptidomimetics, 3D printing technologies and Artificial Intelligence (AI) to prototype multifunctional microneedle wound patches capable of:

Fields of training

(Nano)material science

Pharmaceutical chemistry

3D printing

Toxicology/microbiology

Sensors

Why smart microneedle wound patches?

Wound infections place a significant strain on healthcare systems and are a major cause of sepsis, hospitalisation and antimicrobial resistance. They are often difficult to treat, particularly when bacteria form protective biofilms. Current treatments frequently depend on broad-spectrum antibiotics and slow laboratory tests, which can delay targeted care.

HEAL-4WARD introduces smart microneedle wound patches as an integrated solution. The technology combines advanced nanomaterials, antimicrobial peptidomimetics and label-free sensors in a single platform. This enables real-time detection of infection biomarkers and on-demand antimicrobial action. Supported by 3D printing and artificial intelligence, the approach paves the way for more precise, personalised wound infection management.

Join the network

HEAL4WARD is recruiting 11 highly motivated and talented doctoral candidates to join our interdisciplinary network.

Each position offers a fully funded 36-month doctoral project, international mobility and intersectoral secondments across leading academic, clinical and industrial partners in Europe. If you are interested in working at the interface of nanomaterials, 3D printing, advanced sensing and AI in healthcare, explore the available positions below.

Meet the consortium

HEAL4WARD brings together a highly interdisciplinary and complementary consortium of 16 organisations from eight European countries, spanning academia, research, healthcare, industry and non-profit sectors. The consortium combines expertise in materials, nanotechnology, sensing, additive manufacturing, AI and clinical research. 

Beneficiaries

Associated Partners